NO903169L - 4,1,2-1h-benzoksadiaziner og deres fremstilling. - Google Patents

4,1,2-1h-benzoksadiaziner og deres fremstilling.

Info

Publication number
NO903169L
NO903169L NO90903169A NO903169A NO903169L NO 903169 L NO903169 L NO 903169L NO 90903169 A NO90903169 A NO 90903169A NO 903169 A NO903169 A NO 903169A NO 903169 L NO903169 L NO 903169L
Authority
NO
Norway
Prior art keywords
benzoxadiazines
preparation
Prior art date
Application number
NO90903169A
Other languages
English (en)
Other versions
NO903169D0 (no
Inventor
Jean-Luc Malleron
Daniel Mansuy
Daniel Varech
Guyen Thie-Vuong N
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO903169D0 publication Critical patent/NO903169D0/no
Publication of NO903169L publication Critical patent/NO903169L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO90903169A 1989-07-17 1990-07-16 4,1,2-1h-benzoksadiaziner og deres fremstilling. NO903169L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909590A FR2649612A1 (fr) 1989-07-17 1989-07-17 Medicaments a base de derives de 1h-benzoxadiazine-4,1,2 nouveaux derives et leurs procedes de preparation

Publications (2)

Publication Number Publication Date
NO903169D0 NO903169D0 (no) 1990-07-16
NO903169L true NO903169L (no) 1991-01-18

Family

ID=9383843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90903169A NO903169L (no) 1989-07-17 1990-07-16 4,1,2-1h-benzoksadiaziner og deres fremstilling.

Country Status (8)

Country Link
EP (1) EP0410834A1 (no)
JP (1) JPH0352876A (no)
CA (1) CA2021250A1 (no)
FI (1) FI903589A7 (no)
FR (1) FR2649612A1 (no)
IE (1) IE902587A1 (no)
NO (1) NO903169L (no)
PT (1) PT94729A (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001866A (en) * 1995-10-05 1999-12-14 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
US6077869A (en) * 1998-10-29 2000-06-20 Ortho-Mcneil Pharmaceutical, Inc. Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation
WO2007016525A2 (en) * 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CN102190743B (zh) † 2006-07-25 2013-03-13 三井化学株式会社 乙烯聚合物的制造方法
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
NZ617779A (en) 2009-03-18 2015-08-28 Resverlogix Corp Novel anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
PT2773354T (pt) 2011-11-01 2019-07-17 Resverlogix Corp Formulações orais de libertação imediata para quinazolinonas substituídas
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
CN114349656B (zh) * 2022-01-18 2024-03-29 赣南师范大学 一种酰肼类化合物的制备方法
CN118880357B (zh) * 2024-07-10 2025-09-09 齐齐哈尔医学院 一种苯并噁二嗪衍生物及其电化学合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH487171A (de) * 1963-10-22 1970-03-15 Siegfried Ag Verfahren zur Herstellung therapeutisch wirksamer 1,2-Dihydro-1,2,4-benztriazine

Also Published As

Publication number Publication date
IE902587A1 (en) 1991-02-27
NO903169D0 (no) 1990-07-16
EP0410834A1 (fr) 1991-01-30
PT94729A (pt) 1991-03-20
FI903589A7 (fi) 1991-01-18
JPH0352876A (ja) 1991-03-07
FI903589A0 (fi) 1990-07-16
FR2649612A1 (fr) 1991-01-18
CA2021250A1 (fr) 1991-01-18

Similar Documents

Publication Publication Date Title
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
NO900469L (no) Piperidinforbindelser, deres fremstilling og anvendelse.
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
NO912960D0 (no) Polylaktider, deres fremstilling og anvendelse.
DK462187D0 (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO902279L (no) Benzocykloalkanderivater og deres fremstilling.
NO903169D0 (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO903096L (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO903978D0 (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
DK435289D0 (da) Piperazindioner, deres fremstilling og anvendelse
NO900943D0 (no) Kopolymerer, fremgangsmaate for deres fremstilling og anvendelse.
NO912271D0 (no) Somatostatinpreparater, deres fremstilling og anvendelse.
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
NO924343D0 (no) Substituerte 1,5 pentandioler og deres fremstilling
NO892570L (no) Polysilazaner, deres fremstilling og anvendelse.
NO874926L (no) Kopolymerer, deres fremstilling og anvendelse.
DK388986A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, deres fremstillingog anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO901199L (no) Azol-1-alkanamider og deres fremstilling.
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.